Treace Medical Concepts, Inc.
TMCI
$4.16
$0.102.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -24.51% | 24.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -24.51% | 24.51% | |||
| Cost of Revenue | -19.20% | 15.32% | |||
| Gross Profit | -25.78% | 26.94% | |||
| SG&A Expenses | -3.53% | 4.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.96% | 5.47% | |||
| Operating Income | -189.89% | 59.65% | |||
| Income Before Tax | -91.20% | 42.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -91.20% | 42.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -91.20% | 42.33% | |||
| EBIT | -189.89% | 59.65% | |||
| EBITDA | -295.43% | 65.42% | |||
| EPS Basic | -89.06% | 42.63% | |||
| Normalized Basic EPS | -166.56% | 56.65% | |||
| EPS Diluted | -90.35% | 42.63% | |||
| Normalized Diluted EPS | -166.56% | 56.65% | |||
| Average Basic Shares Outstanding | 1.15% | 0.54% | |||
| Average Diluted Shares Outstanding | 1.15% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||